Global Veterinary Infectious Disease Diagnostics Market Statistics: USD 4.1 Billion Value by 2033

Summary:

• The global veterinary infectious disease diagnostics market size reached USD 2.2 Billion in 2024.
• The market is expected to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033.
• North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share.
• Immunodiagnostics account for the majority of the market share in the technology segment due to their accuracy, cost-effectiveness, and rapid detection capabilities.
• Companion animals hold the largest share in the veterinary infectious disease diagnostics industry.
• Bacterial infections remain a dominant segment in the market.
• Reference laboratories represent the leading end user segment.
• The growing awareness about animal health and welfare is a primary driver of the veterinary infectious disease diagnostics market.
• Advancements in diagnostic technology and the increasing awareness about zoonotic diseases are reshaping the veterinary infectious disease diagnostics market.

Industry Trends and Drivers:

• Advancements in diagnostic technologies:

Technological advancements in diagnostic methods, such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and rapid test kits, are bolstering the market growth. These modern techniques allow for quicker and more accurate detection of pathogens in animals, leading to early interventions and better treatment outcomes. The shift from traditional diagnostic methods to more sophisticated, automated tools is making veterinary care more efficient. Laboratories and clinics offer point-of-care (POC) testing, which provides rapid results and enhances the ability to control the spread of infectious diseases in animals. The continuous development of diagnostic technologies, alongside greater adoption of molecular diagnostics, is making veterinary diagnostics a crucial component of animal healthcare.

• Growing awareness about animal health and welfare:

Governments, non-governmental organizations (NGOs), and animal welfare groups are advocating for better healthcare practices for both pets and farm animals. As awareness spreads, there is a higher emphasis on early diagnosis and treatment of infectious diseases to prevent suffering and improve animal welfare standards. In addition, the implementation of stringent regulations regarding the health status of animals, particularly those used for food production, is driving the demand for regular disease screening. Many countries now require certifications that animals are free of certain infectious diseases before they can be sold or exported, which is leading to a rise in diagnostic testing.

• Increasing awareness about zoonotic diseases:

The rising awareness about zoonotic diseases, which are infectious diseases that can be transmitted between animals and humans, is propelling the market growth. The growing public health concern is increasing attention on preventing diseases originating from animals. Veterinary diagnostics play a crucial role in identifying and controlling zoonotic pathogens in both companion animals and livestock. This focus on animal health as a part of international health is leading to stronger partnerships between veterinary and human health professionals. Besides this, governing bodies and health organizations are emphasizing disease surveillance, which is driving the demand for diagnostic tools to monitor and prevent zoonotic disease transmission.

Request for a sample copy of this report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market/requestsample

Veterinary Infectious Disease Diagnostics Market Report Segmentation:

Breakup By Technology:

• Immunodiagnostics

• Molecular Diagnostics

• Others

Immunodiagnostics exhibit a clear dominance in the market attributed to their accuracy, cost-effectiveness, and rapid detection capabilities.

Breakup By Animal Type:

• Companion Animals

• Food Producing Animals

Companion animals represent the largest segment, driven by the increasing adoption of pets and higher spending on animal health.

Breakup By Infection Type:

• Bacterial Infections

• Viral Infections

• Parasitic Infections

• Others

Bacterial infections hold the biggest market share due to their prevalence and the need for precise diagnosis in animal healthcare.

Breakup By End User:

• Reference Laboratories

• Veterinary Laboratories and Clinics

• Point of Care/In House Testing

• Research Institutes and Universities

Reference laboratories account for the majority of the market share, as they offer specialized, comprehensive diagnostic services.

Breakup By Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

North America leads the market owing to advanced veterinary healthcare infrastructure and high demand for animal diagnostics.

Top Veterinary Infectious Disease Diagnostics Market Leaders:

The veterinary infectious disease diagnostics market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Abbott Laboratories

• Biomérieux SA

• Creative Diagnostics

• HESKA Corporation

• Innovative Diagnostics

• IDEXX Laboratories Inc.

• Neogen Corporation

• Qiagen N.V.

• Randox Laboratories Ltd

• Thermo Fisher Scientific Inc  

• Virbac

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1–631–791–1145